Filing metadata

Accession number
0001193125-25-240563
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Oct 15, 2025
Reporting period
Jun 24, 2025
Description
Insider transaction

Explore SEC Filings Hub